@prefix cito: <http://purl.org/spar/cito/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ex: <https://w3id.org/levin-kg/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/pubinfo> {
    ex:assessment-CHERNET2016-C1 a ex:BayesianAssessment ;
        dcterms:description "Combined assuming independence across evidence items; exact/threshold p-values per figure legend." ;
        ex:bayesFactorCombined 223.581811 ;
        ex:calibrationMethod "Vovk–Sellke p-value calibration (Sellke, Bayarri & Berger, 2001)" ;
        ex:weightOfEvidence_deciban 23.494365 .

    ex:np-CHERNET2016-C1-10.18632_oncotarget.8036 dcterms:bibliographicCitation "Brook T. Chernet; Dany S. Adams; Maria Lobikin; Michael Levin (2016). Use of genetically encoded, light-gated ion translocators to control tumorigenesis. https://doi.org/10.18632/oncotarget.8036" ;
        dcterms:created "2025-10-01"^^xsd:date ;
        dcterms:creator ex:generator ;
        dcterms:identifier "26988909" ;
        dcterms:source <https://doi.org/10.18632/oncotarget.8036> .

    <https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/> dcterms:created "2025-11-04"^^xsd:date ;
        dcterms:source <https://doi.org/10.18632/oncotarget.8036> .

    ex:generator a prov:SoftwareAgent ;
        dcterms:description "Constructs nanopublications with Bayesian weight-of-evidence estimates via Vovk–Sellke calibration." ;
        dcterms:license "CC0-1.0" ;
        dcterms:title "Levin-KG generator (wave Q)" .
}

<https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/provenance> {
    <https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/assertion> prov:wasDerivedFrom <https://doi.org/10.18632/oncotarget.8036> .
}

<https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/assertion> {
    ex:claim-CHERNET2016-C1 a ex:Assertion ;
        dcterms:description "Optogenetic hyperpolarization (Arch or ChR2^{D156A}) significantly prevents KRAS^{G12D}-induced tumor-like structures (ITLS) and promotes regression (normalization) of existing tumors in vivo." ;
        cito:citesAsEvidence <https://doi.org/10.18632/oncotarget.8036> ;
        ex:context "Xenopus laevis tumor model; KRAS^{G12D}; Arch and ChR2^{D156A}; light stimulation regimens; incidence and normalization outcomes; qPCR marker normalization." ;
        ex:hasAssessment ex:assessment-CHERNET2016-C1 ;
        ex:hasEvidence ex:evidence-CHERNET2016-C1-E1,
            ex:evidence-CHERNET2016-C1-E2 .
}

<https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/Head> {
    <https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/> a np:Nanopublication ;
        dcterms:conformsTo <https://w3id.org/morphopkg/spc/1.0> ;
        np:hasAssertion <https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/assertion> ;
        np:hasProvenance <https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/provenance> ;
        np:hasPublicationInfo <https://w3id.org/levin-kg/np/np-CHERNET2016-C1-10.18632_oncotarget.8036/pubinfo> .
}

